Skip to main content

Table 3 Fatty acid composition in liver and WAT of mice given control- or FPH-diets for 2 weeks and fasted over night

From: A fish protein hydrolysate alters fatty acid composition in liver and adipose tissue and increases plasma carnitine levels in a mouse model of chronic inflammation

Fatty acids % (w/w) Liver WAT
  Control FPH Control FPH
∑ SFAs 34.57 ± 0.74 34.81 ± 0.87 32.35 ± 1.08 34.35 ± 1.15*
   C16:0 21.42 ± 0.35 22.19 ± 0.49* 25.26 ± 0.83 26.13 ± 1.31
   C18:0 12.02 ± 0.55 11.49 ± 0.57 4.61 ± 0.45 5.73 ± 0.55**
∑ MUFAs 25.43 ± 0.89 24.25 ± 1.31 48.62 ± 1.17 47.83 ± 2.35
   C16:1n-7 1.03 ± 0.13 1.03 ± 0.12 4.74 ± 0.34 4.51 ± 0.46
   C18:1n- 7 1.60 ± 0.08 1.32 ± 0.09*** 2.22 ± 0.08 2.04 ± 0.04**
   C18:1n- 9 21.77 ± 0.75 21.01 ± 1.15 40.35 ± 1.40 40.08 ± 5.53
n- 6 PUFAs 31.05 ± 0.59 30.52 ± 0.07 17.61 ± 1.38 16.21 ± 1.35
   C18:2n-6 16.00 ± 0.54 17.03 ± 0.75* 16.70 ± 1.41 15.38 ± 1.30
   C20:3n- 6 0.90 ± 0.06 0.76 ± 0.05** 0.15 ± 0.01 0.12 ± 0.01*
   C20:4n- 6 12.96 ± 0.79 11.79 ± 0.57* 0.34 ± 0.04 0.30 ± 0.04
   C22:4n- 6 0.34 ± 0.01 0.25 ± 0.01*** 0.07 ± 0.01 0.06 ± 0.01*
n- 3 PUFAs 8.73 ± 0.65 10.24 ± 0.68** 1.28 ± 0.10 1.49 ± 0.25
   C18:3n-3 0.42 ± 0.03 0.50 ± 0.05* 0.89 ± 0.06 0.98 ± 0.14
   C20:5n- 3 (EPA) 0.29 ± 0.03 0.57 ± 0.10*** 0.03 ± 0.01 0.06 ± 0.02**
   C22:5n- 3 0.29 ± 0.02 0.42 ± 0.02*** 0.07 ± 0.01 0.09 ± 0.02*
   C22:6n- 3 (DHA) 7.60 ± 0.65 8.60 ± 0.60* 0.24 ± 0.03 0.32 ± 0.07
n- 3:∑ n- 6 ratio 0.28 ± 0.35 0.34 ± 0.02** 0.07 ± 0.01 0.09 ± 0.01**
  1. Abbreviations: DHA docosahexaenoic acid, EPA eicosapentaenoic acid, FPH fish protein hydrolysate, MUFA monounsaturated fatty acids, PUFA polyunsaturated fatty acids, SFA saturated fatty acids, WAT white adipose tissue.
  2. Data are means ± SD (n = 5). Values significantly different from control are indicated (*P < 0.05,**P < 0.01,***P < 0.001).